临床试验/NCT01622582

NCT01622582已完成不适用

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

University of Arkansas1 个研究点分布在 1 个国家目标入组 796 人开始时间: 2006年1月最近更新: 2015年3月3日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: University of Arkansas
入组人数: 796
试验地点: 1
主要终点: number of patients developing Engraftment syndrome following stem cell transplant

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Engraftment Syndrome after Autologous Stem Cell Transplant: Retrospective Review in Patients with Multiple Myeloma

详细描述

A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.

研究设计

研究类型: Observational
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients with Multiple Myeloma, developing engraftment syndrome

排除标准

•Patients with Multiple Myeloma, with no features of engraftment syndrome

结局指标

主要结局

number of patients developing Engraftment syndrome following stem cell transplant

时间窗: 6 months post-transplant

A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

次要结局

未报告次要终点

研究者

发起方

University of Arkansas

申办方类型

Other

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Mesenchymal stem cell transplantation in the treatment of type 1 diabetic patientsType 1 diabetes.Insulin-dependent diabetes mellitus

IRCT138810271414N8Endocrinology & Metabolism Research Center20

招募中

1 期

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRDMultiple Myeloma

NCT05192122University of Illinois at Chicago50

已完成

2 期

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host DiseaseHematological Malignancies

NCT00504803University of Liege30

暂停

1 期

Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant PatientsCoronary DiseaseHeart Transplant

NCT02472002Assistance Publique - Hôpitaux de Paris14

尚未招募

不适用

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II studyRefractory or relapsed Chronic Lymphocytic Leukemia

NL-OMON27777Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 7041560Fax: 010 7041028e-mail: hdc@erasmusmc.nl50